Research on a vulnerable population shows serious cardio benefits with flaxseed.
A new study on flax and blood pressure could change the perception that consumers know little of flax’s health benefits. The study was presented at the American Heart Association’s 2012 Scientific Sessions.
The Flax Council of Canada reports that 110 subjects with peripheral arterial disease (PAD) were assigned to milled flax (30 g daily) in bagels, muffins, and buns or placebo products. After six months, subjects in the flax group experienced statistically significant decreases in systolic blood pressure (10 mm Hg) and diastolic blood pressure (7 mm Hg). When the researchers performed subgroup analysis on just the PAD patients with high blood pressure, results were even better: an estimated 15 mm Hg drop in systolic blood pressure and a similar drop in diastolic blood pressure.
“This is the largest decrease in blood pressure ever shown by any dietary intervention, including the Mediterranean Diet and low-sodium diets,” said lead researcher Grant Pierce, PhD, of St. Boniface Hospital (Winnipeg, MB, Canada). “We expect that this kind of improvement in people with hypertension could reduce their incidence of heart attack and stroke by 50%.”
Flax for the study was provided by Glanbia Nutritionals.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.